Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Efficacy and Safety of Artemether-Lumefantrine Plus Primaquine for Uncomplicated Plasmodium Falciparum Malaria and Chloroquine Plus Primaquine for Uncomplicated Plasmodium Vivax Malaria in Ethiopia: A Multi-center, Open-label Observational Study

NCT07840898 is registered in ClinicalTrials.gov with Ethiopian Public Health Institute as lead sponsor.

NCT NCT07840898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07840898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Efficacy and Safety of Artemether-Lumefantrine Plus Primaquine for Uncomplicated Plasmodium Falciparum Malaria and Chloroquine Plus Primaquine for Uncomplicated Plasmodium Vivax Malaria in Ethiopia: A Multi-center, Open-label Observational Study
Lead sponsor
Ethiopian Public Health Institute
Phase
Observational
Overall status
Not yet recruiting
Start date
October 20, 2026
Completion date
March 30, 2027
Enrollment
1,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

plasmodium falciparum malaria (uncomplicated), plasmodium vivax malaria without complication